Monoclonal antibody to human trk-A: Diagnostic and therapeutic potential in neuroblastoma

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 2090-2091

  Kramer, K ^a   Gerald, W ^a   Lesauteur, L ^b   Saragovi, H U ^b,c   Cheung, N K V ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Neuroblastoma; p140 trk A nerve growth factor receptor; Paediatric malignancies; Trk A

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN RECEPTOR; TYROSINE KINASE RECEPTOR;

ANTIBODY SPECIFICITY; CANCER IMMUNOTHERAPY; CANCER STAGING; CHILDHOOD CANCER; CONFERENCE PAPER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; NEOPLASM PROTEINS; NEUROBLASTOMA; RECEPTOR, TRKA;

EID: 0031427181     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00210-4     Document Type: Conference Paper

References (10)

1. Matsushima H., Bogenmann E. Nerve growth factor (NGF) induces neuronal differentiation in neuroblastoma cells transfected with the NGF receptor cDNA. Mol Cell Biol. 10:1990;5015-5020.
2. Yankner B. A., Shooter E. M. The biology and mechanism of action of nerve growth factor. Annu Rev Biochem. 51:1982;845-868.
3. Nakagawara A., Arima-Nakagawara M., Scavarda N. J., et al. Association between high levels of Trk gene and favorable outcome in human neuroblastoma. N Engl J Med. 328:1993;847-854.
4. Suzuki T., Bogenmann E., Shimada M., Stram D., Seeger R. C. Lack of high affinity nerve growth receptors in aggressive neuroblastoma. J Natl Cancer Inst. 85:1993;377-384.
5. LeSauteur L., Maliartchouk S., LeJeune H., Quirion R., Saragovi H. U. Potent human p140-TrkA agonist derived from an anti-receptor monoclonal antibody. J Neurosci. 16:1996;1308-1316.
6. LeSauteur L, Lisbona R, Saragovi HU. In vivo imaging of nerve growth factor receptors with small molecule analogs of nerve growth factor, in press.
7. Nakagawara A, Milbrandt J, Muramatsu T, et al. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res 1995, 55, 1792-1797.
8. Nakagawara A., Azar C., Scavarda N. J., Brodeur G. M. Expression and function of Trk-B and BDNF in human neuroblastomas. Mol Cell Biol. 14:1994;759-767.
9. Matsumato K., Wada R. K., Yamashiro J. M., Kaplan D. R., Thiele C. J. Expression of brain-derived neurotrophic factor and p145 TrkB affects survival, differentiation and invasiveness of human neuroblastoma cells. Cancer Res. 55:1995;1798-1806.
10. LeSauteur L., Wei L., Gibbs B. F., Saragovi H. U. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J Biol Chem. 270:1995;6564-6569.